
Off-Patent Therapy Restores Brain Connectivity in Multiple Sclerosis
Administering an off-patent compound alongside standard care improves functional brain connectivity in people with multiple sclerosis. Investigators at Thomas Jefferson University reported the clinical imaging results in IBRO Neuroscience Reports, identifying a treatment route that addresses nerve cell damage. The therapeutic protocol relies on replenishing depleted antioxidant defenses within the central nervous system.





